1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survey results from a patient's perspective during a phase I/research clinic visit
    Meeting Abstract

    Beltran, S. V.; MacIntyre, J.; Tejera, D.; Merchan, J. R.; Watts, J. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Long-term survival in women with high-grade serous ovarian cancer: Interplay between RB1 and BRCA1/2
    Meeting Abstract

    Saner, F. A. M.; Garsed, D. W.; Beach, J. A.; Pandey, A.; Fereday, S.; Alsop, K.; Wouters, M. C. A.; Traficante, N.; Pearce, C. L.; Pike, M. C.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: Efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the phase III SOLO1 trial
    Meeting Abstract

    Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Effect of progression-free interval (PFI) following penultimate platinum-based regimen on the efficacy of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: An analysis from the phase 3 study ARIEL3
    Meeting Abstract

    Clamp, A. R.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Scambia, G.; Leary, A.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Patient-centred outcomes in the phase 3 study ARIEL3 of rucaparib maintenance treatment in patients with platinum-sensitive, recurrent ovarian carcinoma: Post hoc exploratory analyses by BRCA mutation status and patient age
    Meeting Abstract

    Colombo, N.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; Leary, A.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: Results of GROINSS-V II
    Meeting Abstract

    Oonk, M. H. M.; Slomovitz, B.; Baldwin, P.; van Doorn, H.; van der Velden, J.; de Hullu, J.; Slangen, B.; Gaarenstroom, K.; Vergote, I.; Brannstrom, M.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • A phase I/II study of durvalumab and stereotactic radiotherapy in locally advanced pancreatic cancer
    Meeting Abstract

    Tuli, R.; Nissen, N.; Lo, S.; Tighiouart, M.; Placencio, V.; Hendifar, A.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Identifying mechanisms of macrophage-mediated metastasis and therapy resistance in PDAC
    Meeting Abstract

    Wu, T. J.; Cast, O.; Memon, D.; Jimenez-Sanchez, A.; Machel, A.; Kehrloesser, S.; Gill, M. B.; Miller, M. L.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Keratin 17 drives tumor aggression and could be targeted for treatment of pancreatic ductal adenocarcinoma
    Meeting Abstract

    Shroyer, K. R.; Escobar-Hoyos, L.; Leiton, C.; Pan, C. H.; Kawalerski, R.; Roa-Peña, L.; Babu, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study
    Meeting Abstract

    Gonzalez-Martin, A.; Pothuri, B.; Vergote, I.; Christensen, R. D.; Graybill, W.; Mirza, M. R.; McCormick, C.; Lorusso, D.; Hoskins, P.; Freyer, G.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save